Filing Details

Accession Number:
0001209191-20-065578
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-30 18:12:13
Reporting Period:
2020-12-30
Accepted Time:
2020-12-30 18:12:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166287 T Derek Chalmers C/O Cara Therapeutics, Inc.
4 Stamford Plaza, 107 Elm St, 9Th Floor
Stamford CT 06902
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-30 6,078 $15.30 936,593 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of the RSUs reported on Form 4 filed with the Securities and Exchange Commission on December 29, 2020, and does not represent a discretionary trade by the Reporting Person.
  2. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (1).